A retrospective review of the pharmacy computer database was performed to identify hemodialysis patients with central venous catheters who received alteplase or urokinase for presumed catheter ...

Urokinase breaks down harmful blood clots that have formed in the blood vessels. It is used to treat patients who have ...

Medindia neither buys nor sells drugs. Urokinase (Urolyte) is an enzyme (thrombolytic agent), prescribed for deep vein thrombosis, heart attack, pulmonary embolism and peripheral vascular occlusion.

Monopar Therapeutics (MNPR) on Tuesday announced the filing of a provisional patent application regarding the recent ...

The antibody MNPR-101 targets the urokinase plasminogen activator receptor (uPAR), which is expressed on numerous tumor types including pancreatic, breast, colorectal, and bladder. The study is ...

WHY KIDNEY DISEASES ARE MORE COMMON IN BLACKS Compared to the white population, blacks are more than 3 times as likely to ...

Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix ®), a life sciences innovator, manufacturer, and exporter, announces that Labquality Ltd., a collaborator and customer, is presenting results ...

The most common clot-busting drugs include Activase (alteplase), Streptase (streptokinase), and Kinlytic (urokinase). Surgery and other specialist procedures are sometimes necessary when ...

Thirty-eight patients received alteplase, and 36 patients received urokinase. Of these patients, 11 patients in the alteplase group and 26 patients in the urokinase group were excluded from the ...